nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER1—breast cancer	0.172	0.426	CbGaD
Dinoprostone—HPGDS—breast cancer	0.117	0.29	CbGaD
Dinoprostone—SLCO1B1—breast cancer	0.0784	0.194	CbGaD
Dinoprostone—CYP19A1—Exemestane—breast cancer	0.0494	0.146	CbGbCtD
Dinoprostone—CYP19A1—Letrozole—breast cancer	0.042	0.124	CbGbCtD
Dinoprostone—CYP19A1—Anastrozole—breast cancer	0.0374	0.111	CbGbCtD
Dinoprostone—CYP19A1—breast cancer	0.0363	0.09	CbGaD
Dinoprostone—SLCO1A2—Chlorambucil—breast cancer	0.0222	0.0656	CbGbCtD
Dinoprostone—ABCC5—Fluorouracil—breast cancer	0.0209	0.0619	CbGbCtD
Dinoprostone—CYP19A1—Raloxifene—breast cancer	0.0189	0.056	CbGbCtD
Dinoprostone—SLCO3A1—Methotrexate—breast cancer	0.018	0.0534	CbGbCtD
Dinoprostone—CYP19A1—Tamoxifen—breast cancer	0.0125	0.037	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—breast cancer	0.0115	0.0341	CbGbCtD
Dinoprostone—SLC22A7—Fluorouracil—breast cancer	0.0103	0.0304	CbGbCtD
Dinoprostone—ABCC4—Fluorouracil—breast cancer	0.01	0.0297	CbGbCtD
Dinoprostone—CYP19A1—Paclitaxel—breast cancer	0.00973	0.0288	CbGbCtD
Dinoprostone—CYP1A2—Anastrozole—breast cancer	0.00905	0.0268	CbGbCtD
Dinoprostone—CYP1A2—Toremifene—breast cancer	0.00828	0.0245	CbGbCtD
Dinoprostone—SLC22A7—Docetaxel—breast cancer	0.00785	0.0232	CbGbCtD
Dinoprostone—SLCO1B1—Irinotecan—breast cancer	0.00709	0.021	CbGbCtD
Dinoprostone—SLC22A2—Vinblastine—breast cancer	0.00678	0.0201	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—breast cancer	0.00595	0.0176	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—breast cancer	0.00567	0.0168	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—breast cancer	0.00554	0.0164	CbGbCtD
Dinoprostone—PTGFR—corpus luteum—breast cancer	0.00511	0.0911	CbGeAlD
Dinoprostone—SLCO1A2—Methotrexate—breast cancer	0.00398	0.0118	CbGbCtD
Dinoprostone—CYP11A1—corpus luteum—breast cancer	0.00389	0.0694	CbGeAlD
Dinoprostone—SLCO1B1—Methotrexate—breast cancer	0.00375	0.0111	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—breast cancer	0.00346	0.0102	CbGbCtD
Dinoprostone—CYP1A2—Tamoxifen—breast cancer	0.00302	0.00894	CbGbCtD
Dinoprostone—CYP19A1—corpus luteum—breast cancer	0.00253	0.0451	CbGeAlD
Dinoprostone—SLC22A6—Methotrexate—breast cancer	0.00241	0.00713	CbGbCtD
Dinoprostone—CYP1A2—Fluorouracil—breast cancer	0.00223	0.00659	CbGbCtD
Dinoprostone—PTGER3—mammary gland—breast cancer	0.00099	0.0177	CbGeAlD
Dinoprostone—Carboprost Tromethamine—PTGER1—breast cancer	0.00089	0.221	CrCbGaD
Dinoprostone—SLC51B—endometrium—breast cancer	0.0008	0.0143	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—FABP7—breast cancer	0.000789	0.196	CrCbGaD
Dinoprostone—PTGFR—nipple—breast cancer	0.000654	0.0117	CbGeAlD
Dinoprostone—PTGER4—epithelium—breast cancer	0.000651	0.0116	CbGeAlD
Dinoprostone—SLC51B—adrenal gland—breast cancer	0.000647	0.0115	CbGeAlD
Dinoprostone—Epoprostenol—PTGER1—breast cancer	0.000617	0.153	CrCbGaD
Dinoprostone—PTGER2—endometrium—breast cancer	0.000595	0.0106	CbGeAlD
Dinoprostone—HPGDS—embryo—breast cancer	0.000584	0.0104	CbGeAlD
Dinoprostone—PTGER4—endometrium—breast cancer	0.000584	0.0104	CbGeAlD
Dinoprostone—SLC51B—endocrine gland—breast cancer	0.000561	0.01	CbGeAlD
Dinoprostone—SLCO4A1—mammary gland—breast cancer	0.000561	0.01	CbGeAlD
Dinoprostone—Bimatoprost—PTGER1—breast cancer	0.000559	0.138	CrCbGaD
Dinoprostone—ABCC5—mammary gland—breast cancer	0.000557	0.00994	CbGeAlD
Dinoprostone—PTGER2—uterus—breast cancer	0.000548	0.00977	CbGeAlD
Dinoprostone—PTGER4—uterus—breast cancer	0.000538	0.00959	CbGeAlD
Dinoprostone—PTGER2—adipose tissue—breast cancer	0.000536	0.00956	CbGeAlD
Dinoprostone—PTGER4—adipose tissue—breast cancer	0.000526	0.00938	CbGeAlD
Dinoprostone—SLCO3A1—nipple—breast cancer	0.000509	0.00908	CbGeAlD
Dinoprostone—SLCO2A1—nipple—breast cancer	0.000504	0.00899	CbGeAlD
Dinoprostone—SLCO1B1—mammary gland—breast cancer	0.000493	0.0088	CbGeAlD
Dinoprostone—PTGER2—female reproductive system—breast cancer	0.000493	0.00879	CbGeAlD
Dinoprostone—PTGER4—female reproductive system—breast cancer	0.000483	0.00862	CbGeAlD
Dinoprostone—PTGER2—adrenal gland—breast cancer	0.000481	0.00857	CbGeAlD
Dinoprostone—HPGDS—epithelium—breast cancer	0.000476	0.0085	CbGeAlD
Dinoprostone—SLC51A—female reproductive system—breast cancer	0.000475	0.00847	CbGeAlD
Dinoprostone—PTGER4—adrenal gland—breast cancer	0.000472	0.00842	CbGeAlD
Dinoprostone—PTGER1—female reproductive system—breast cancer	0.000467	0.00833	CbGeAlD
Dinoprostone—PTGER2—bone marrow—breast cancer	0.000465	0.0083	CbGeAlD
Dinoprostone—SLCO4A1—nipple—breast cancer	0.000464	0.00827	CbGeAlD
Dinoprostone—SLC51A—adrenal gland—breast cancer	0.000463	0.00827	CbGeAlD
Dinoprostone—PTGER3—uterus—breast cancer	0.000455	0.00812	CbGeAlD
Dinoprostone—PTGER2—female gonad—breast cancer	0.000448	0.008	CbGeAlD
Dinoprostone—PTGER3—adipose tissue—breast cancer	0.000445	0.00795	CbGeAlD
Dinoprostone—PTGER4—female gonad—breast cancer	0.00044	0.00785	CbGeAlD
Dinoprostone—SLCO2B1—mammary gland—breast cancer	0.000436	0.00778	CbGeAlD
Dinoprostone—HPGDS—endometrium—breast cancer	0.000427	0.00762	CbGeAlD
Dinoprostone—PTGER1—female gonad—breast cancer	0.000425	0.00758	CbGeAlD
Dinoprostone—Alprostadil—PTGER1—breast cancer	0.000423	0.105	CrCbGaD
Dinoprostone—PTGER3—female reproductive system—breast cancer	0.000409	0.0073	CbGeAlD
Dinoprostone—PTGER4—endocrine gland—breast cancer	0.000409	0.0073	CbGeAlD
Dinoprostone—SLC51A—endocrine gland—breast cancer	0.000402	0.00717	CbGeAlD
Dinoprostone—PTGER3—adrenal gland—breast cancer	0.0004	0.00713	CbGeAlD
Dinoprostone—PTGER1—endocrine gland—breast cancer	0.000395	0.00705	CbGeAlD
Dinoprostone—HPGDS—uterus—breast cancer	0.000394	0.00702	CbGeAlD
Dinoprostone—PTGIR—epithelium—breast cancer	0.000388	0.00693	CbGeAlD
Dinoprostone—HPGDS—adipose tissue—breast cancer	0.000385	0.00687	CbGeAlD
Dinoprostone—PTGER3—female gonad—breast cancer	0.000373	0.00665	CbGeAlD
Dinoprostone—PTGFR—uterus—breast cancer	0.000364	0.0065	CbGeAlD
Dinoprostone—PTGFR—adipose tissue—breast cancer	0.000356	0.00635	CbGeAlD
Dinoprostone—HPGDS—female reproductive system—breast cancer	0.000354	0.00631	CbGeAlD
Dinoprostone—PTGER3—endocrine gland—breast cancer	0.000346	0.00618	CbGeAlD
Dinoprostone—HPGDS—adrenal gland—breast cancer	0.000345	0.00616	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—breast cancer	0.000339	0.00606	CbGeAlD
Dinoprostone—Dinoprost Tromethamine—PTGER1—breast cancer	0.000338	0.0839	CrCbGaD
Dinoprostone—HPGDS—bone marrow—breast cancer	0.000334	0.00596	CbGeAlD
Dinoprostone—PTGFR—female reproductive system—breast cancer	0.000327	0.00584	CbGeAlD
Dinoprostone—SLCO2A1—skin of body—breast cancer	0.000323	0.00576	CbGeAlD
Dinoprostone—HPGDS—female gonad—breast cancer	0.000322	0.00574	CbGeAlD
Dinoprostone—PTGFR—adrenal gland—breast cancer	0.000319	0.0057	CbGeAlD
Dinoprostone—SLCO1C1—pituitary gland—breast cancer	0.000316	0.00564	CbGeAlD
Dinoprostone—SLCO1C1—adipose tissue—breast cancer	0.000315	0.00562	CbGeAlD
Dinoprostone—PTGIR—adipose tissue—breast cancer	0.000314	0.0056	CbGeAlD
Dinoprostone—SLCO2A1—endometrium—breast cancer	0.000304	0.00543	CbGeAlD
Dinoprostone—HPGDS—endocrine gland—breast cancer	0.000299	0.00534	CbGeAlD
Dinoprostone—PTGFR—female gonad—breast cancer	0.000298	0.00531	CbGeAlD
Dinoprostone—PTGIR—female reproductive system—breast cancer	0.000288	0.00515	CbGeAlD
Dinoprostone—PTGER2—lymph node—breast cancer	0.000288	0.00514	CbGeAlD
Dinoprostone—PTGER4—lymph node—breast cancer	0.000283	0.00505	CbGeAlD
Dinoprostone—PTGIR—adrenal gland—breast cancer	0.000282	0.00502	CbGeAlD
Dinoprostone—SLC22A11—female reproductive system—breast cancer	0.000281	0.00501	CbGeAlD
Dinoprostone—SLCO2A1—uterus—breast cancer	0.00028	0.005	CbGeAlD
Dinoprostone—SLCO4A1—endometrium—breast cancer	0.00028	0.00499	CbGeAlD
Dinoprostone—SLCO3A1—pituitary gland—breast cancer	0.000278	0.00496	CbGeAlD
Dinoprostone—SLC51A—lymph node—breast cancer	0.000278	0.00496	CbGeAlD
Dinoprostone—PTGFR—endocrine gland—breast cancer	0.000277	0.00494	CbGeAlD
Dinoprostone—SLCO3A1—adipose tissue—breast cancer	0.000277	0.00494	CbGeAlD
Dinoprostone—SLCO2A1—pituitary gland—breast cancer	0.000275	0.00491	CbGeAlD
Dinoprostone—SLCO2A1—adipose tissue—breast cancer	0.000274	0.00489	CbGeAlD
Dinoprostone—CYP11A1—adipose tissue—breast cancer	0.000271	0.00484	CbGeAlD
Dinoprostone—PTGIR—female gonad—breast cancer	0.000262	0.00468	CbGeAlD
Dinoprostone—SLCO3A1—female reproductive system—breast cancer	0.000255	0.00454	CbGeAlD
Dinoprostone—SLCO4A1—pituitary gland—breast cancer	0.000253	0.00452	CbGeAlD
Dinoprostone—SLCO4A1—adipose tissue—breast cancer	0.000252	0.0045	CbGeAlD
Dinoprostone—SLCO2A1—female reproductive system—breast cancer	0.000252	0.0045	CbGeAlD
Dinoprostone—ABCC5—pituitary gland—breast cancer	0.000252	0.00449	CbGeAlD
Dinoprostone—ABCC5—adipose tissue—breast cancer	0.000251	0.00448	CbGeAlD
Dinoprostone—CYP11A1—female reproductive system—breast cancer	0.000249	0.00445	CbGeAlD
Dinoprostone—SLCO3A1—adrenal gland—breast cancer	0.000248	0.00443	CbGeAlD
Dinoprostone—SLCO2A1—adrenal gland—breast cancer	0.000246	0.00439	CbGeAlD
Dinoprostone—SLCO1C1—endocrine gland—breast cancer	0.000245	0.00437	CbGeAlD
Dinoprostone—PTGIR—endocrine gland—breast cancer	0.000244	0.00435	CbGeAlD
Dinoprostone—CYP11A1—adrenal gland—breast cancer	0.000243	0.00434	CbGeAlD
Dinoprostone—PTGER3—lymph node—breast cancer	0.00024	0.00427	CbGeAlD
Dinoprostone—SLC22A11—endocrine gland—breast cancer	0.000238	0.00424	CbGeAlD
Dinoprostone—SLC22A7—endocrine gland—breast cancer	0.000232	0.00414	CbGeAlD
Dinoprostone—SLCO4A1—female reproductive system—breast cancer	0.000232	0.00414	CbGeAlD
Dinoprostone—SLCO3A1—female gonad—breast cancer	0.000232	0.00413	CbGeAlD
Dinoprostone—Dinoprost Tromethamine—HPGDS—breast cancer	0.00023	0.057	CrCbGaD
Dinoprostone—SLCO2A1—female gonad—breast cancer	0.000229	0.00409	CbGeAlD
Dinoprostone—CYP11A1—female gonad—breast cancer	0.000227	0.00405	CbGeAlD
Dinoprostone—SLCO4A1—adrenal gland—breast cancer	0.000226	0.00404	CbGeAlD
Dinoprostone—ABCC5—adrenal gland—breast cancer	0.000225	0.00401	CbGeAlD
Dinoprostone—ABCC5—bone marrow—breast cancer	0.000218	0.00388	CbGeAlD
Dinoprostone—CYP1A2—nipple—breast cancer	0.000217	0.00387	CbGeAlD
Dinoprostone—SLCO3A1—endocrine gland—breast cancer	0.000215	0.00384	CbGeAlD
Dinoprostone—SLCO2A1—endocrine gland—breast cancer	0.000213	0.00381	CbGeAlD
Dinoprostone—CYP11A1—endocrine gland—breast cancer	0.000211	0.00377	CbGeAlD
Dinoprostone—ABCC5—female gonad—breast cancer	0.00021	0.00374	CbGeAlD
Dinoprostone—HPGDS—lymph node—breast cancer	0.000207	0.00369	CbGeAlD
Dinoprostone—SLCO1B1—female reproductive system—breast cancer	0.000204	0.00364	CbGeAlD
Dinoprostone—SLCO2B1—uterus—breast cancer	0.000201	0.00358	CbGeAlD
Dinoprostone—SLCO2B1—adipose tissue—breast cancer	0.000196	0.0035	CbGeAlD
Dinoprostone—SLCO4A1—endocrine gland—breast cancer	0.000196	0.0035	CbGeAlD
Dinoprostone—CYP19A1—endometrium—breast cancer	0.000196	0.00349	CbGeAlD
Dinoprostone—PTGFR—lymph node—breast cancer	0.000191	0.00342	CbGeAlD
Dinoprostone—SLC22A1—adipose tissue—breast cancer	0.000188	0.00335	CbGeAlD
Dinoprostone—SLCO2B1—female reproductive system—breast cancer	0.00018	0.00322	CbGeAlD
Dinoprostone—CYP19A1—uterus—breast cancer	0.00018	0.00322	CbGeAlD
Dinoprostone—ABCC4—uterus—breast cancer	0.000178	0.00317	CbGeAlD
Dinoprostone—CYP19A1—adipose tissue—breast cancer	0.000176	0.00315	CbGeAlD
Dinoprostone—SLCO2B1—adrenal gland—breast cancer	0.000176	0.00314	CbGeAlD
Dinoprostone—ABCC4—adipose tissue—breast cancer	0.000174	0.0031	CbGeAlD
Dinoprostone—SLCO1B1—endocrine gland—breast cancer	0.000173	0.00308	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—breast cancer	0.000169	0.00302	CbGeAlD
Dinoprostone—PTGIR—lymph node—breast cancer	0.000169	0.00301	CbGeAlD
Dinoprostone—SLCO2B1—female gonad—breast cancer	0.000164	0.00293	CbGeAlD
Dinoprostone—CYP19A1—female reproductive system—breast cancer	0.000162	0.00289	CbGeAlD
Dinoprostone—ABCC4—female reproductive system—breast cancer	0.00016	0.00285	CbGeAlD
Dinoprostone—CYP19A1—adrenal gland—breast cancer	0.000158	0.00282	CbGeAlD
Dinoprostone—ABCC4—adrenal gland—breast cancer	0.000156	0.00278	CbGeAlD
Dinoprostone—SLCO2B1—endocrine gland—breast cancer	0.000153	0.00272	CbGeAlD
Dinoprostone—ABCC4—bone marrow—breast cancer	0.000151	0.00269	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—breast cancer	0.000149	0.00266	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—breast cancer	0.000148	0.00263	CbGeAlD
Dinoprostone—CYP19A1—female gonad—breast cancer	0.000147	0.00263	CbGeAlD
Dinoprostone—SLC22A1—endocrine gland—breast cancer	0.000146	0.0026	CbGeAlD
Dinoprostone—CYP11A1—lymph node—breast cancer	0.000146	0.0026	CbGeAlD
Dinoprostone—ABCC4—female gonad—breast cancer	0.000145	0.00259	CbGeAlD
Dinoprostone—SLCO1A2—endocrine gland—breast cancer	0.000141	0.00251	CbGeAlD
Dinoprostone—CYP19A1—endocrine gland—breast cancer	0.000137	0.00245	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—breast cancer	0.000136	0.00242	CbGeAlD
Dinoprostone—ABCC4—endocrine gland—breast cancer	0.000135	0.00241	CbGeAlD
Dinoprostone—ABCC5—lymph node—breast cancer	0.000135	0.00241	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS1—breast cancer	0.00012	0.0296	CrCbGaD
Dinoprostone—SLCO2B1—lymph node—breast cancer	0.000106	0.00188	CbGeAlD
Dinoprostone—CYP19A1—lymph node—breast cancer	9.48e-05	0.00169	CbGeAlD
Dinoprostone—ABCC4—lymph node—breast cancer	9.35e-05	0.00167	CbGeAlD
Dinoprostone—CYP1A2—endocrine gland—breast cancer	9.19e-05	0.00164	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—breast cancer	6.83e-05	0.0169	CrCbGaD
Dinoprostone—Arrhythmia—Capecitabine—breast cancer	4.9e-05	0.000515	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—breast cancer	4.86e-05	0.000511	CcSEcCtD
Dinoprostone—Pain—Gemcitabine—breast cancer	4.86e-05	0.00051	CcSEcCtD
Dinoprostone—Asthenia—Thiotepa—breast cancer	4.84e-05	0.000509	CcSEcCtD
Dinoprostone—Diarrhoea—Vinorelbine—breast cancer	4.84e-05	0.000508	CcSEcCtD
Dinoprostone—Nausea—Melphalan—breast cancer	4.8e-05	0.000505	CcSEcCtD
Dinoprostone—Asthma—Epirubicin—breast cancer	4.78e-05	0.000502	CcSEcCtD
Dinoprostone—Back pain—Docetaxel—breast cancer	4.78e-05	0.000502	CcSEcCtD
Dinoprostone—Pain—Fluorouracil—breast cancer	4.77e-05	0.000501	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Irinotecan—breast cancer	4.77e-05	0.000501	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Mitoxantrone—breast cancer	4.77e-05	0.000501	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—breast cancer	4.76e-05	0.0005	CcSEcCtD
Dinoprostone—Anaphylactic shock—Paclitaxel—breast cancer	4.75e-05	0.000499	CcSEcCtD
Dinoprostone—Muscle spasms—Docetaxel—breast cancer	4.75e-05	0.000498	CcSEcCtD
Dinoprostone—Nausea—Goserelin—breast cancer	4.69e-05	0.000492	CcSEcCtD
Dinoprostone—Shock—Paclitaxel—breast cancer	4.68e-05	0.000491	CcSEcCtD
Dinoprostone—Dizziness—Vinorelbine—breast cancer	4.67e-05	0.000491	CcSEcCtD
Dinoprostone—Tachycardia—Paclitaxel—breast cancer	4.64e-05	0.000487	CcSEcCtD
Dinoprostone—Back pain—Capecitabine—breast cancer	4.62e-05	0.000486	CcSEcCtD
Dinoprostone—Diarrhoea—Thiotepa—breast cancer	4.62e-05	0.000485	CcSEcCtD
Dinoprostone—Abdominal pain—Mitoxantrone—breast cancer	4.61e-05	0.000484	CcSEcCtD
Dinoprostone—Abdominal pain—Irinotecan—breast cancer	4.61e-05	0.000484	CcSEcCtD
Dinoprostone—Body temperature increased—Mitoxantrone—breast cancer	4.61e-05	0.000484	CcSEcCtD
Dinoprostone—Body temperature increased—Irinotecan—breast cancer	4.61e-05	0.000484	CcSEcCtD
Dinoprostone—Muscle spasms—Capecitabine—breast cancer	4.6e-05	0.000483	CcSEcCtD
Dinoprostone—Hyperhidrosis—Paclitaxel—breast cancer	4.6e-05	0.000483	CcSEcCtD
Dinoprostone—Vision blurred—Capecitabine—breast cancer	4.5e-05	0.000473	CcSEcCtD
Dinoprostone—Vomiting—Vinorelbine—breast cancer	4.49e-05	0.000472	CcSEcCtD
Dinoprostone—Body temperature increased—Gemcitabine—breast cancer	4.49e-05	0.000471	CcSEcCtD
Dinoprostone—Tremor—Capecitabine—breast cancer	4.48e-05	0.00047	CcSEcCtD
Dinoprostone—Dizziness—Thiotepa—breast cancer	4.46e-05	0.000469	CcSEcCtD
Dinoprostone—Rash—Vinorelbine—breast cancer	4.46e-05	0.000468	CcSEcCtD
Dinoprostone—Dermatitis—Vinorelbine—breast cancer	4.45e-05	0.000468	CcSEcCtD
Dinoprostone—Hypotension—Paclitaxel—breast cancer	4.44e-05	0.000466	CcSEcCtD
Dinoprostone—Headache—Vinorelbine—breast cancer	4.43e-05	0.000465	CcSEcCtD
Dinoprostone—Syncope—Docetaxel—breast cancer	4.43e-05	0.000465	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—breast cancer	4.42e-05	0.000464	CcSEcCtD
Dinoprostone—Body temperature increased—Fluorouracil—breast cancer	4.41e-05	0.000463	CcSEcCtD
Dinoprostone—Loss of consciousness—Docetaxel—breast cancer	4.34e-05	0.000456	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.33e-05	0.000455	CcSEcCtD
Dinoprostone—Cough—Docetaxel—breast cancer	4.31e-05	0.000452	CcSEcCtD
Dinoprostone—Hypersensitivity—Irinotecan—breast cancer	4.29e-05	0.000451	CcSEcCtD
Dinoprostone—Hypersensitivity—Mitoxantrone—breast cancer	4.29e-05	0.000451	CcSEcCtD
Dinoprostone—Vomiting—Thiotepa—breast cancer	4.29e-05	0.000451	CcSEcCtD
Dinoprostone—Syncope—Capecitabine—breast cancer	4.29e-05	0.00045	CcSEcCtD
Dinoprostone—Paraesthesia—Paclitaxel—breast cancer	4.27e-05	0.000448	CcSEcCtD
Dinoprostone—Hypertension—Docetaxel—breast cancer	4.26e-05	0.000448	CcSEcCtD
Dinoprostone—Rash—Thiotepa—breast cancer	4.26e-05	0.000447	CcSEcCtD
Dinoprostone—Dermatitis—Thiotepa—breast cancer	4.25e-05	0.000447	CcSEcCtD
Dinoprostone—Dyspnoea—Paclitaxel—breast cancer	4.24e-05	0.000445	CcSEcCtD
Dinoprostone—Headache—Thiotepa—breast cancer	4.23e-05	0.000444	CcSEcCtD
Dinoprostone—Arthralgia—Docetaxel—breast cancer	4.2e-05	0.000441	CcSEcCtD
Dinoprostone—Myalgia—Docetaxel—breast cancer	4.2e-05	0.000441	CcSEcCtD
Dinoprostone—Chest pain—Docetaxel—breast cancer	4.2e-05	0.000441	CcSEcCtD
Dinoprostone—Loss of consciousness—Capecitabine—breast cancer	4.2e-05	0.000441	CcSEcCtD
Dinoprostone—Nausea—Vinorelbine—breast cancer	4.2e-05	0.000441	CcSEcCtD
Dinoprostone—Asthenia—Mitoxantrone—breast cancer	4.18e-05	0.000439	CcSEcCtD
Dinoprostone—Asthenia—Irinotecan—breast cancer	4.18e-05	0.000439	CcSEcCtD
Dinoprostone—Cough—Capecitabine—breast cancer	4.17e-05	0.000438	CcSEcCtD
Dinoprostone—Hypertension—Capecitabine—breast cancer	4.13e-05	0.000433	CcSEcCtD
Dinoprostone—Hypersensitivity—Fluorouracil—breast cancer	4.11e-05	0.000432	CcSEcCtD
Dinoprostone—Asthenia—Gemcitabine—breast cancer	4.07e-05	0.000428	CcSEcCtD
Dinoprostone—Chest pain—Capecitabine—breast cancer	4.07e-05	0.000427	CcSEcCtD
Dinoprostone—Arthralgia—Capecitabine—breast cancer	4.07e-05	0.000427	CcSEcCtD
Dinoprostone—Myalgia—Capecitabine—breast cancer	4.07e-05	0.000427	CcSEcCtD
Dinoprostone—Pain—Paclitaxel—breast cancer	4.06e-05	0.000427	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—breast cancer	4.06e-05	0.000426	CcSEcCtD
Dinoprostone—Anaphylactic shock—Docetaxel—breast cancer	4.03e-05	0.000423	CcSEcCtD
Dinoprostone—Nausea—Thiotepa—breast cancer	4.01e-05	0.000421	CcSEcCtD
Dinoprostone—Diarrhoea—Mitoxantrone—breast cancer	3.99e-05	0.000419	CcSEcCtD
Dinoprostone—Diarrhoea—Irinotecan—breast cancer	3.99e-05	0.000419	CcSEcCtD
Dinoprostone—Shock—Docetaxel—breast cancer	3.96e-05	0.000416	CcSEcCtD
Dinoprostone—Tachycardia—Docetaxel—breast cancer	3.93e-05	0.000413	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Paclitaxel—breast cancer	3.89e-05	0.000408	CcSEcCtD
Dinoprostone—Diarrhoea—Gemcitabine—breast cancer	3.88e-05	0.000408	CcSEcCtD
Dinoprostone—Dizziness—Irinotecan—breast cancer	3.85e-05	0.000405	CcSEcCtD
Dinoprostone—Shock—Capecitabine—breast cancer	3.84e-05	0.000403	CcSEcCtD
Dinoprostone—Diarrhoea—Fluorouracil—breast cancer	3.82e-05	0.000401	CcSEcCtD
Dinoprostone—Tachycardia—Capecitabine—breast cancer	3.81e-05	0.0004	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—breast cancer	3.8e-05	0.000399	CcSEcCtD
Dinoprostone—Hyperhidrosis—Capecitabine—breast cancer	3.77e-05	0.000396	CcSEcCtD
Dinoprostone—Hypotension—Docetaxel—breast cancer	3.76e-05	0.000395	CcSEcCtD
Dinoprostone—Abdominal pain—Paclitaxel—breast cancer	3.76e-05	0.000395	CcSEcCtD
Dinoprostone—Body temperature increased—Paclitaxel—breast cancer	3.76e-05	0.000395	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—breast cancer	3.71e-05	0.000389	CcSEcCtD
Dinoprostone—Vomiting—Mitoxantrone—breast cancer	3.71e-05	0.000389	CcSEcCtD
Dinoprostone—Vomiting—Irinotecan—breast cancer	3.71e-05	0.000389	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—breast cancer	3.69e-05	0.000388	CcSEcCtD
Dinoprostone—Dizziness—Fluorouracil—breast cancer	3.69e-05	0.000388	CcSEcCtD
Dinoprostone—Rash—Irinotecan—breast cancer	3.67e-05	0.000386	CcSEcCtD
Dinoprostone—Rash—Mitoxantrone—breast cancer	3.67e-05	0.000386	CcSEcCtD
Dinoprostone—Dermatitis—Irinotecan—breast cancer	3.67e-05	0.000386	CcSEcCtD
Dinoprostone—Dermatitis—Mitoxantrone—breast cancer	3.67e-05	0.000386	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Docetaxel—breast cancer	3.67e-05	0.000386	CcSEcCtD
Dinoprostone—Chills—Methotrexate—breast cancer	3.67e-05	0.000385	CcSEcCtD
Dinoprostone—Headache—Irinotecan—breast cancer	3.65e-05	0.000383	CcSEcCtD
Dinoprostone—Headache—Mitoxantrone—breast cancer	3.65e-05	0.000383	CcSEcCtD
Dinoprostone—Hypotension—Capecitabine—breast cancer	3.65e-05	0.000383	CcSEcCtD
Dinoprostone—Paraesthesia—Docetaxel—breast cancer	3.62e-05	0.00038	CcSEcCtD
Dinoprostone—Vomiting—Gemcitabine—breast cancer	3.61e-05	0.000379	CcSEcCtD
Dinoprostone—Dyspnoea—Docetaxel—breast cancer	3.59e-05	0.000377	CcSEcCtD
Dinoprostone—Rash—Gemcitabine—breast cancer	3.58e-05	0.000376	CcSEcCtD
Dinoprostone—Dermatitis—Gemcitabine—breast cancer	3.58e-05	0.000376	CcSEcCtD
Dinoprostone—Headache—Gemcitabine—breast cancer	3.56e-05	0.000374	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.55e-05	0.000373	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—breast cancer	3.55e-05	0.000373	CcSEcCtD
Dinoprostone—Vomiting—Fluorouracil—breast cancer	3.55e-05	0.000373	CcSEcCtD
Dinoprostone—Rash—Fluorouracil—breast cancer	3.52e-05	0.00037	CcSEcCtD
Dinoprostone—Dermatitis—Fluorouracil—breast cancer	3.52e-05	0.000369	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—breast cancer	3.51e-05	0.000369	CcSEcCtD
Dinoprostone—Paraesthesia—Capecitabine—breast cancer	3.5e-05	0.000368	CcSEcCtD
Dinoprostone—Hypersensitivity—Paclitaxel—breast cancer	3.5e-05	0.000368	CcSEcCtD
Dinoprostone—Headache—Fluorouracil—breast cancer	3.5e-05	0.000367	CcSEcCtD
Dinoprostone—Dyspnoea—Capecitabine—breast cancer	3.48e-05	0.000365	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—breast cancer	3.47e-05	0.000364	CcSEcCtD
Dinoprostone—Nausea—Irinotecan—breast cancer	3.46e-05	0.000364	CcSEcCtD
Dinoprostone—Nausea—Mitoxantrone—breast cancer	3.46e-05	0.000364	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—breast cancer	3.45e-05	0.000363	CcSEcCtD
Dinoprostone—Pain—Docetaxel—breast cancer	3.45e-05	0.000362	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—breast cancer	3.44e-05	0.000361	CcSEcCtD
Dinoprostone—Chills—Epirubicin—breast cancer	3.43e-05	0.00036	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—breast cancer	3.42e-05	0.000359	CcSEcCtD
Dinoprostone—Asthenia—Paclitaxel—breast cancer	3.41e-05	0.000358	CcSEcCtD
Dinoprostone—Nausea—Gemcitabine—breast cancer	3.37e-05	0.000354	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—breast cancer	3.35e-05	0.000352	CcSEcCtD
Dinoprostone—Pain—Capecitabine—breast cancer	3.34e-05	0.00035	CcSEcCtD
Dinoprostone—Nausea—Fluorouracil—breast cancer	3.32e-05	0.000348	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Docetaxel—breast cancer	3.29e-05	0.000346	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—breast cancer	3.28e-05	0.000345	CcSEcCtD
Dinoprostone—Tension—Epirubicin—breast cancer	3.27e-05	0.000343	CcSEcCtD
Dinoprostone—Diarrhoea—Paclitaxel—breast cancer	3.25e-05	0.000342	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—breast cancer	3.22e-05	0.000338	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—breast cancer	3.21e-05	0.000337	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—breast cancer	3.2e-05	0.000336	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—breast cancer	3.2e-05	0.000336	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Capecitabine—breast cancer	3.19e-05	0.000335	CcSEcCtD
Dinoprostone—Abdominal pain—Docetaxel—breast cancer	3.18e-05	0.000335	CcSEcCtD
Dinoprostone—Body temperature increased—Docetaxel—breast cancer	3.18e-05	0.000335	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—breast cancer	3.18e-05	0.000334	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—breast cancer	3.16e-05	0.000332	CcSEcCtD
Dinoprostone—Dizziness—Paclitaxel—breast cancer	3.14e-05	0.00033	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—breast cancer	3.14e-05	0.00033	CcSEcCtD
Dinoprostone—Cough—Methotrexate—breast cancer	3.1e-05	0.000326	CcSEcCtD
Dinoprostone—Body temperature increased—Capecitabine—breast cancer	3.08e-05	0.000324	CcSEcCtD
Dinoprostone—Abdominal pain—Capecitabine—breast cancer	3.08e-05	0.000324	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—breast cancer	3.03e-05	0.000318	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—breast cancer	3.03e-05	0.000318	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—breast cancer	3.03e-05	0.000318	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—breast cancer	3.02e-05	0.000318	CcSEcCtD
Dinoprostone—Vomiting—Paclitaxel—breast cancer	3.02e-05	0.000317	CcSEcCtD
Dinoprostone—Rash—Paclitaxel—breast cancer	3e-05	0.000315	CcSEcCtD
Dinoprostone—Dermatitis—Paclitaxel—breast cancer	2.99e-05	0.000314	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—breast cancer	2.99e-05	0.000314	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—breast cancer	2.98e-05	0.000313	CcSEcCtD
Dinoprostone—Headache—Paclitaxel—breast cancer	2.98e-05	0.000313	CcSEcCtD
Dinoprostone—Hypersensitivity—Docetaxel—breast cancer	2.97e-05	0.000312	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—breast cancer	2.96e-05	0.000311	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—breast cancer	2.93e-05	0.000307	CcSEcCtD
Dinoprostone—Cough—Epirubicin—breast cancer	2.91e-05	0.000305	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—breast cancer	2.9e-05	0.000305	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—breast cancer	2.9e-05	0.000305	CcSEcCtD
Dinoprostone—Asthenia—Docetaxel—breast cancer	2.89e-05	0.000304	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—breast cancer	2.87e-05	0.000302	CcSEcCtD
Dinoprostone—Hypersensitivity—Capecitabine—breast cancer	2.87e-05	0.000302	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—breast cancer	2.83e-05	0.000298	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—breast cancer	2.83e-05	0.000298	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—breast cancer	2.83e-05	0.000298	CcSEcCtD
Dinoprostone—Nausea—Paclitaxel—breast cancer	2.82e-05	0.000297	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—breast cancer	2.81e-05	0.000295	CcSEcCtD
Dinoprostone—Asthenia—Capecitabine—breast cancer	2.8e-05	0.000294	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—breast cancer	2.76e-05	0.00029	CcSEcCtD
Dinoprostone—Diarrhoea—Docetaxel—breast cancer	2.76e-05	0.00029	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—breast cancer	2.72e-05	0.000285	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—breast cancer	2.71e-05	0.000285	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—breast cancer	2.71e-05	0.000284	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—breast cancer	2.69e-05	0.000282	CcSEcCtD
Dinoprostone—Shock—Epirubicin—breast cancer	2.67e-05	0.000281	CcSEcCtD
Dinoprostone—Diarrhoea—Capecitabine—breast cancer	2.67e-05	0.00028	CcSEcCtD
Dinoprostone—Dizziness—Docetaxel—breast cancer	2.66e-05	0.00028	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—breast cancer	2.66e-05	0.000279	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—breast cancer	2.65e-05	0.000279	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.65e-05	0.000278	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—breast cancer	2.63e-05	0.000276	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—breast cancer	2.62e-05	0.000275	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—breast cancer	2.62e-05	0.000275	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—breast cancer	2.62e-05	0.000275	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—breast cancer	2.61e-05	0.000274	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—breast cancer	2.59e-05	0.000272	CcSEcCtD
Dinoprostone—Dizziness—Capecitabine—breast cancer	2.58e-05	0.000271	CcSEcCtD
Dinoprostone—Vomiting—Docetaxel—breast cancer	2.56e-05	0.000269	CcSEcCtD
Dinoprostone—Rash—Docetaxel—breast cancer	2.54e-05	0.000267	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—breast cancer	2.54e-05	0.000267	CcSEcCtD
Dinoprostone—Dermatitis—Docetaxel—breast cancer	2.54e-05	0.000267	CcSEcCtD
Dinoprostone—Headache—Docetaxel—breast cancer	2.52e-05	0.000265	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—breast cancer	2.51e-05	0.000264	CcSEcCtD
Dinoprostone—Pain—Methotrexate—breast cancer	2.48e-05	0.000261	CcSEcCtD
Dinoprostone—Vomiting—Capecitabine—breast cancer	2.48e-05	0.00026	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.48e-05	0.00026	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—breast cancer	2.47e-05	0.00026	CcSEcCtD
Dinoprostone—Rash—Capecitabine—breast cancer	2.46e-05	0.000258	CcSEcCtD
Dinoprostone—Dermatitis—Capecitabine—breast cancer	2.46e-05	0.000258	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—breast cancer	2.45e-05	0.000258	CcSEcCtD
Dinoprostone—Headache—Capecitabine—breast cancer	2.44e-05	0.000257	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—breast cancer	2.44e-05	0.000256	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—breast cancer	2.43e-05	0.000255	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—breast cancer	2.42e-05	0.000254	CcSEcCtD
Dinoprostone—Nausea—Docetaxel—breast cancer	2.39e-05	0.000251	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—breast cancer	2.37e-05	0.000249	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—breast cancer	2.35e-05	0.000247	CcSEcCtD
Dinoprostone—Pain—Epirubicin—breast cancer	2.32e-05	0.000244	CcSEcCtD
Dinoprostone—Nausea—Capecitabine—breast cancer	2.32e-05	0.000243	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—breast cancer	2.3e-05	0.000241	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—breast cancer	2.3e-05	0.000241	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.29e-05	0.000241	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—breast cancer	2.26e-05	0.000237	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—breast cancer	2.24e-05	0.000235	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—breast cancer	2.22e-05	0.000233	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—breast cancer	2.15e-05	0.000226	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—breast cancer	2.15e-05	0.000226	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—breast cancer	2.15e-05	0.000226	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—breast cancer	2.14e-05	0.000225	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—breast cancer	2.08e-05	0.000219	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—breast cancer	2.06e-05	0.000216	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—breast cancer	2e-05	0.00021	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—breast cancer	1.99e-05	0.000209	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—breast cancer	1.99e-05	0.000209	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—breast cancer	1.99e-05	0.000209	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—breast cancer	1.95e-05	0.000205	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—breast cancer	1.92e-05	0.000202	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—breast cancer	1.86e-05	0.000195	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—breast cancer	1.85e-05	0.000195	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—breast cancer	1.85e-05	0.000194	CcSEcCtD
Dinoprostone—Rash—Methotrexate—breast cancer	1.83e-05	0.000192	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—breast cancer	1.83e-05	0.000192	CcSEcCtD
Dinoprostone—Headache—Methotrexate—breast cancer	1.82e-05	0.000191	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—breast cancer	1.8e-05	0.000189	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—breast cancer	1.8e-05	0.000189	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—breast cancer	1.73e-05	0.000181	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—breast cancer	1.72e-05	0.000181	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—breast cancer	1.72e-05	0.000181	CcSEcCtD
Dinoprostone—Rash—Epirubicin—breast cancer	1.71e-05	0.00018	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—breast cancer	1.71e-05	0.00018	CcSEcCtD
Dinoprostone—Headache—Epirubicin—breast cancer	1.7e-05	0.000179	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—breast cancer	1.66e-05	0.000175	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—breast cancer	1.61e-05	0.00017	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—breast cancer	1.6e-05	0.000168	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—breast cancer	1.59e-05	0.000167	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—breast cancer	1.58e-05	0.000166	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—breast cancer	1.58e-05	0.000165	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—breast cancer	1.49e-05	0.000157	CcSEcCtD
Dinoprostone—SLCO1B1—Metabolism—ERCC2—breast cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—COMT—breast cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TYMS—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—breast cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARGC1B—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—breast cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NCOR1—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PLA2G4A—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ITPR1—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—breast cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.35e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—breast cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CB—breast cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—breast cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—breast cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—breast cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—breast cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—breast cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—breast cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.33e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.33e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—breast cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—breast cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—breast cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—breast cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—breast cancer	1.33e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—breast cancer	1.32e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—breast cancer	1.32e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—breast cancer	1.32e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—breast cancer	1.31e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—breast cancer	1.31e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—breast cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—breast cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX1—breast cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—breast cancer	1.3e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—breast cancer	1.3e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—breast cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—breast cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—breast cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—breast cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA4—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA9—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP1A1—breast cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—breast cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—breast cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TYMS—breast cancer	1.29e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ERCC2—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CAV1—breast cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.28e-06	1.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PLA2G4A—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NCOR1—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX2—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA2—breast cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—breast cancer	1.25e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—breast cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX4—breast cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SULT1A1—breast cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—breast cancer	1.23e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—breast cancer	1.22e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTA1—breast cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH1—breast cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX1—breast cancer	1.22e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAV1—breast cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—breast cancer	1.21e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1A1—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NAT2—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—breast cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—breast cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—breast cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ERCC2—breast cancer	1.19e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—breast cancer	1.18e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—breast cancer	1.17e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—breast cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—breast cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—breast cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—breast cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.16e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—breast cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CD—breast cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—breast cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—breast cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAV1—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—breast cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—breast cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—breast cancer	1.11e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—breast cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—breast cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—breast cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.09e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—breast cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—breast cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—breast cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—breast cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—breast cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—breast cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MED12—breast cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DPYD—breast cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—breast cancer	1.05e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—breast cancer	1.05e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDOA—breast cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—breast cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAV1—breast cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CD—breast cancer	1.03e-06	9.97e-06	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—breast cancer	1.02e-06	9.91e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—breast cancer	1.02e-06	9.87e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—breast cancer	1.01e-06	9.84e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—breast cancer	1.01e-06	9.83e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA3—breast cancer	1.01e-06	9.8e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A2—breast cancer	1e-06	9.73e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—breast cancer	9.95e-07	9.66e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—breast cancer	9.95e-07	9.66e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—breast cancer	9.94e-07	9.66e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.91e-07	9.63e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CB—breast cancer	9.9e-07	9.62e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCG2—breast cancer	9.81e-07	9.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CPT1A—breast cancer	9.81e-07	9.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTR—breast cancer	9.81e-07	9.53e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—breast cancer	9.81e-07	9.53e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CD—breast cancer	9.71e-07	9.43e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—breast cancer	9.69e-07	9.42e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HPGDS—breast cancer	9.62e-07	9.35e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—breast cancer	9.58e-07	9.31e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HBA1—breast cancer	9.56e-07	9.29e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—breast cancer	9.43e-07	9.17e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—breast cancer	9.4e-07	9.13e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—breast cancer	9.34e-07	9.07e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—breast cancer	9.33e-07	9.07e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACHE—breast cancer	9.33e-07	9.07e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—breast cancer	9.17e-07	8.91e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—breast cancer	9.17e-07	8.91e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—breast cancer	9.14e-07	8.88e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—breast cancer	9.14e-07	8.88e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—breast cancer	9.03e-07	8.78e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CB—breast cancer	8.94e-07	8.69e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CD—breast cancer	8.9e-07	8.65e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—breast cancer	8.86e-07	8.61e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—breast cancer	8.84e-07	8.59e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—breast cancer	8.84e-07	8.59e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP17A1—breast cancer	8.83e-07	8.58e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—breast cancer	8.78e-07	8.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO1—breast cancer	8.74e-07	8.5e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS1—breast cancer	8.74e-07	8.5e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.71e-07	8.47e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—breast cancer	8.64e-07	8.39e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.6e-07	8.36e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2D6—breast cancer	8.58e-07	8.33e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—breast cancer	8.55e-07	8.31e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CB—breast cancer	8.46e-07	8.22e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—breast cancer	8.45e-07	8.22e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—breast cancer	8.45e-07	8.22e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA2—breast cancer	8.42e-07	8.18e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—breast cancer	8.4e-07	8.16e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—breast cancer	8.39e-07	8.15e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CD—breast cancer	8.29e-07	8.06e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—breast cancer	8.27e-07	8.03e-06	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—breast cancer	8.23e-07	8e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—breast cancer	8.19e-07	7.95e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FASN—breast cancer	8.16e-07	7.93e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BCHE—breast cancer	8.13e-07	7.9e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—breast cancer	8.09e-07	7.86e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—breast cancer	8.09e-07	7.86e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A5—breast cancer	8.03e-07	7.8e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—breast cancer	7.83e-07	7.61e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NQO1—breast cancer	7.76e-07	7.54e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A1—breast cancer	7.76e-07	7.54e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CB—breast cancer	7.75e-07	7.54e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—breast cancer	7.73e-07	7.51e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—breast cancer	7.68e-07	7.47e-06	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—breast cancer	7.68e-07	7.46e-06	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—breast cancer	7.63e-07	7.41e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.59e-07	7.38e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP3A4—breast cancer	7.56e-07	7.35e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.52e-07	7.31e-06	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—breast cancer	7.46e-07	7.25e-06	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—breast cancer	7.46e-07	7.25e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1B1—breast cancer	7.44e-07	7.23e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—breast cancer	7.31e-07	7.11e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSP90AA1—breast cancer	7.29e-07	7.09e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CB—breast cancer	7.23e-07	7.02e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—breast cancer	7.16e-07	6.96e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA1—breast cancer	7.09e-07	6.89e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STK11—breast cancer	6.99e-07	6.79e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP19A1—breast cancer	6.99e-07	6.79e-06	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—breast cancer	6.72e-07	6.53e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—breast cancer	6.7e-07	6.51e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.56e-07	6.38e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—COMT—breast cancer	6.5e-07	6.32e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—breast cancer	6.47e-07	6.29e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—breast cancer	6.38e-07	6.2e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ITPR1—breast cancer	6.36e-07	6.18e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—breast cancer	6.25e-07	6.07e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—breast cancer	6.12e-07	5.95e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—breast cancer	6.03e-07	5.86e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TYMS—breast cancer	6.01e-07	5.84e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOR1—breast cancer	5.94e-07	5.78e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—breast cancer	5.94e-07	5.78e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G4A—breast cancer	5.94e-07	5.78e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX1—breast cancer	5.69e-07	5.53e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1A1—breast cancer	5.63e-07	5.48e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ERCC2—breast cancer	5.59e-07	5.43e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—breast cancer	5.45e-07	5.3e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—breast cancer	5.25e-07	5.1e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—breast cancer	5.16e-07	5.01e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—breast cancer	4.93e-07	4.79e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAV1—breast cancer	4.85e-07	4.71e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—breast cancer	4.73e-07	4.59e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.63e-07	4.5e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—breast cancer	4.45e-07	4.33e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—breast cancer	4.41e-07	4.29e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—breast cancer	4.41e-07	4.28e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—breast cancer	4.21e-07	4.1e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CD—breast cancer	3.88e-07	3.77e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—breast cancer	3.86e-07	3.75e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—breast cancer	3.83e-07	3.72e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—breast cancer	3.66e-07	3.56e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—breast cancer	3.6e-07	3.5e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CB—breast cancer	3.38e-07	3.29e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—breast cancer	3.35e-07	3.26e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—breast cancer	2.92e-07	2.84e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—breast cancer	2.06e-07	2e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—breast cancer	1.68e-07	1.64e-06	CbGpPWpGaD
